| Clinical and biomarker changes in dominantly inherited Alzheimer's disease RJ Bateman, C Xiong, TLS Benzinger, AM Fagan, A Goate, NC Fox, ... New England Journal of Medicine 367 (9), 795-804, 2012 | 4079 | 2012 |
| Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ... The Lancet Neurology 13 (6), 614-629, 2014 | 3635 | 2014 |
| Decreased clearance of CNS β-amyloid in Alzheimer’s disease KG Mawuenyega, W Sigurdson, V Ovod, L Munsell, T Kasten, JC Morris, ... Science 330 (6012), 1774-1774, 2010 | 2356 | 2010 |
| Lecanemab in early Alzheimer’s disease CH Van Dyck, CJ Swanson, P Aisen, RJ Bateman, C Chen, M Gee, ... New England Journal of Medicine 388 (1), 9-21, 2023 | 2095 | 2023 |
| Alzheimer's disease CL Masters, R Bateman, K Blennow, CC Rowe, RA Sperling, ... Nature reviews disease primers 1 (1), 1-18, 2015 | 1803 | 2015 |
| Amyloid-β dynamics are regulated by orexin and the sleep-wake cycle JE Kang, MM Lim, RJ Bateman, JJ Lee, LP Smyth, JR Cirrito, N Fujiki, ... Science 326 (5955), 1005-1007, 2009 | 1654 | 2009 |
| Human apoE isoforms differentially regulate brain amyloid-β peptide clearance JM Castellano, J Kim, FR Stewart, H Jiang, RB DeMattos, BW Patterson, ... Science translational medicine 3 (89), 89ra57-89ra57, 2011 | 1406 | 2011 |
| Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ... Nature medicine 25 (2), 277-283, 2019 | 771 | 2019 |
| Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo RJ Bateman, LY Munsell, JC Morris, R Swarm, KE Yarasheski, ... Nature medicine 12 (7), 856-861, 2006 | 739 | 2006 |
| High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis SE Schindler, JG Bollinger, V Ovod, KG Mawuenyega, Y Li, BA Gordon, ... Neurology 93 (17), e1647-e1659, 2019 | 696 | 2019 |
| Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease RJ Bateman, PS Aisen, B De Strooper, NC Fox, CA Lemere, JM Ringman, ... Alzheimer's research & therapy 3, 1-13, 2011 | 641 | 2011 |
| Sleep-wake cycle and diurnal fluctuation of amyloid-β as biomarkers of brain amyloid pathology JH Roh, Y Huang, AW Bero, T Kasten, FR Stewart, RJ Bateman, ... Science translational medicine 4 (150), 150ra122, 2012 | 609* | 2012 |
| Tau kinetics in neurons and the human central nervous system C Sato, NR Barthélemy, KG Mawuenyega, BW Patterson, BA Gordon, ... Neuron 97 (6), 1284-1298. e7, 2018 | 552 | 2018 |
| Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study BA Gordon, TM Blazey, Y Su, A Hari-Raj, A Dincer, S Flores, ... The Lancet Neurology 17 (3), 241-250, 2018 | 528 | 2018 |
| Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis V Ovod, KN Ramsey, KG Mawuenyega, JG Bollinger, T Hicks, ... Alzheimer's & Dementia 13 (8), 841-849, 2017 | 526 | 2017 |
| Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis DC Ryman, N Acosta-Baena, PS Aisen, T Bird, A Danek, NC Fox, A Goate, ... Neurology 83 (3), 253-260, 2014 | 522 | 2014 |
| White matter hyperintensities are a core feature of Alzheimer's disease: evidence from the dominantly inherited Alzheimer network S Lee, F Viqar, ME Zimmerman, A Narkhede, G Tosto, TLS Benzinger, ... Annals of neurology 79 (6), 929-939, 2016 | 505 | 2016 |
| A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease NR Barthélemy, Y Li, N Joseph-Mathurin, BA Gordon, J Hassenstab, ... Nature medicine 26 (3), 398-407, 2020 | 454 | 2020 |
| Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer’s disease AM Fagan, C Xiong, MS Jasielec, RJ Bateman, AM Goate, TLS Benzinger, ... Science translational medicine 6 (226), 226ra30-226ra30, 2014 | 422 | 2014 |
| Matrix metalloproteinase-9 degrades amyloid-β fibrils in vitro and compact plaques in situ P Yan, X Hu, H Song, K Yin, RJ Bateman, JR Cirrito, Q Xiao, FF Hsu, ... Journal of Biological Chemistry 281 (34), 24566-24574, 2006 | 422 | 2006 |
Tammie L.S. Benzinger, MD, PhDProfessor of Radiology and Neurosurgery, Washington University School of Medicine in Saint Louis在 wustl.edu 的电子邮件经过验证
